Clinical Trial Update: A Study Evaluating Biomarkers in Participants With Heart Failure (MK-0000-344) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating biomarkers in participants with heart failure (MK-0000-344) sponsored by Merck Sharp & Dohme LLC has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Heart Failure | Phase 1 | Status: WITHDRAWN